Myocet liposomal

doxorubicin hydrochloride liposome · CHEPLAPHARM Arzneimittel GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Myocet liposomal, covering 2024-06-06 to 2024-06-06. Get the full timeline:

Most recent: EMA Authorised: Myocet liposomal (previously Myocet) (doxorubicin hydrochloride) — CHEPLAPHARM Arzneimittel GmbH